Literature DB >> 26875698

Unique features associated with hepatic oxidative DNA damage and DNA methylation in non-alcoholic fatty liver disease.

Naoshi Nishida1, Norihisa Yada2, Satoru Hagiwara2, Toshiharu Sakurai2, Masayuki Kitano2, Masatoshi Kudo2.   

Abstract

BACKGROUND AND AIM: Non-alcoholic fatty liver disease (NAFLD) is an increasing cause of hepatocellular carcinoma (HCC). Previously, we reported that DNA oxidation induced epigenetic alteration of tumor suppressor genes (TSGs) and contributed to HCC emergence. Here, we examine the associations between clinicopathological characteristics of NAFLD and advanced oxidative DNA damage that is associated with TSG methylation in the NAFLD liver.
METHODS: Liver biopsies from 65 NAFLD patients were analyzed for clinicopathological features and oxidative DNA damage using immunohistochemistry of 8-hydroxydeoxyguanosine (8-OHdG). Abnormal DNA methylation in the promoters of 6 TSGs, HIC1, GSTP1, SOCS1, RASSF1, CDKN2A, and APC, was examined using MethyLight. Associations between clinicopathological characteristics, methylation of TSGs, and accumulation of 8-OHdG were analyzed.
RESULTS: We found that aspartate aminotransferase/alanine aminotransferase ratio, the fibrosis-4 index, and serum α-fetoprotein (AFP) level were associated with degree of 8-OHdG, and AFP was an independent factor among them (P = 0.0271). Regarding pathological findings, hepatocellular ballooning and stage of fibrosis were also associated with oxidative DNA damage (P = 0.0021 and 0.0054); ballooning was an independent risk for detecting high degree of 8-OHdG in hepatocytes (odds ratio 7.38, 95% confidence interval 1.41-49.13, P = 0.0171). Accumulation of methylated TSGs was significantly associated with deposition of 8-OHdG (P = 0.0362).
CONCLUSIONS: Patients with high serum AFP and high degree of ballooning showed accumulation of oxidative DNA damage that could be a seed of DNA methylation responsible for hepatocarcinogenesis. These characteristics could be risk of HCC; such patients require urgent intervention such as lifestyle modification.
© 2016 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  hepatocarcinogenesis; methylation; nonalcoholic steatohepatitis; oxidative stress; tumor suppressor gene

Mesh:

Substances:

Year:  2016        PMID: 26875698     DOI: 10.1111/jgh.13318

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  14 in total

Review 1.  Hepatocellular carcinoma.

Authors:  Josep M Llovet; Robin Kate Kelley; Augusto Villanueva; Amit G Singal; Eli Pikarsky; Sasan Roayaie; Riccardo Lencioni; Kazuhiko Koike; Jessica Zucman-Rossi; Richard S Finn
Journal:  Nat Rev Dis Primers       Date:  2021-01-21       Impact factor: 52.329

Review 2.  From NASH to HCC: current concepts and future challenges.

Authors:  Quentin M Anstee; Helen L Reeves; Elena Kotsiliti; Olivier Govaere; Mathias Heikenwalder
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-07       Impact factor: 46.802

Review 3.  Insights into the Role and Interdependence of Oxidative Stress and Inflammation in Liver Diseases.

Authors:  Sha Li; Ming Hong; Hor-Yue Tan; Ning Wang; Yibin Feng
Journal:  Oxid Med Cell Longev       Date:  2016-12-14       Impact factor: 6.543

4.  Contribution of C1485T mutation in the HBx gene to human and murine hepatocarcinogenesis.

Authors:  Satoru Hagiwara; Naoshi Nishida; Ah-Mee Park; Yoriaki Komeda; Toshiharu Sakurai; Tomohiro Watanabe; Masatoshi Kudo
Journal:  Sci Rep       Date:  2017-09-05       Impact factor: 4.379

Review 5.  To die or not to die: death signaling in nonalcoholic fatty liver disease.

Authors:  Yuko Akazawa; Kazuhiko Nakao
Journal:  J Gastroenterol       Date:  2018-03-24       Impact factor: 7.527

6.  Expression of IL-17 and its gene promoter methylation status are associated with the progression of chronic hepatitis B virus infection.

Authors:  Cui-Huan Tian; Jun Dai; Wei Zhang; Yan Liu; Yan Yang
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

Review 7.  Oxidative stress in obesity-associated hepatocellular carcinoma: sources, signaling and therapeutic challenges.

Authors:  Manoja K Brahma; Eduardo H Gilglioni; Lang Zhou; Eric Trépo; Pengyu Chen; Esteban N Gurzov
Journal:  Oncogene       Date:  2021-07-21       Impact factor: 8.756

8.  Association between alpha-fetoprotein and metabolic syndrome in a Chinese asymptomatic population: a cross-sectional study.

Authors:  Yimin Chen; Ying Zhao; Linmin Feng; Jie Zhang; Juanwen Zhang; Guofang Feng
Journal:  Lipids Health Dis       Date:  2016-04-27       Impact factor: 3.876

9.  Preoperative transcatheter arterial chemotherapy may suppress oxidative stress in hepatocellular carcinoma cells and reduce the risk of short-term relapse.

Authors:  Hao Su; Guangzhi Zhu; Ketut Indra Djaja P; Yi Lin; Yizhen Gong; Xiaoguang Liu; Jiaquan Li; Zhiming Liu; Xiao Qin; Lequn Li; Tangwei Liu; Zili Lu; Minyi Wei; Lunan Yan; Cheryl Ann Winkler; Stephen J O'Brien; Jing Li; Kaiyin Xiao; Tao Peng
Journal:  Oncotarget       Date:  2017-05-07

10.  Molecular links between non-alcoholic fatty liver disease and hepatocellular carcinoma.

Authors:  Sana Raza; Sangam Rajak; Baby Anjum; Rohit A Sinha
Journal:  Hepatoma Res       Date:  2019-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.